Author: Nichols Martin|| Date Published: July 8, 2020
Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.
The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.
Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.
ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.
The acquisition will combine Precise Systems’ engineering, software development and interactive training capabilities with Ternion’s modeling and simulation tech Ternion…
Navy has five open solicitations covering shipyard, hypersonics, propulsion, training and fabrication The contracts range from small business research funding…
SAIC will provide systems engineering, technical integration and mission support for ground-based intelligence programs The recompete award pushes SAIC’s Intel…
